申请人:REDX PHARMA PLC
公开号:US20160113928A1
公开(公告)日:2016-04-28
This invention relates to novel compounds of formula (I). The compounds of the invention are hedgehog pathway antagonists. Specifically, the compounds of the invention are useful as Smoothened (SMO) inhibitors. The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of the Hedgehog pathway and SMO, for example cancer.
本发明涉及一种新的化合物,其化学式为(I)。该发明的化合物是刺猬信号通路拮抗剂。具体而言,该发明的化合物可用作平滑蛋白(SMO)抑制剂。本发明还考虑使用这些化合物来治疗通过抑制刺猬通路和SMO可治疗的疾病,例如癌症。